| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/12/2003 | CN1454649A Exothermic therapeutic bag of Chinese herbal medicine and preparing method thereof |
| 11/12/2003 | CN1454642A Tonifying capsule preparing process |
| 11/12/2003 | CN1454639A Skin-haemorrhoids-clearing ointment and preparing method thereof |
| 11/12/2003 | CN1454638A Sun-shielding cream and manufacturing method thereof |
| 11/12/2003 | CN1454637A Chapstick and preparing method thereof |
| 11/12/2003 | CN1454634A Capsule for curing asynodia, spermatorrhea, nephralgia and osphyalgia |
| 11/12/2003 | CN1454632A Full gastrodia soft capsule and preparing method thereof |
| 11/12/2003 | CN1454618A Quick-acting haemorrhoids ointment (suppository) |
| 11/12/2003 | CN1454612A Cigarette for health-care and cure |
| 11/12/2003 | CN1454602A High water-soluble povidone-iodine cream |
| 11/12/2003 | CN1454600A Hiliezdum fast-release tablet and preparing method thereof |
| 11/12/2003 | CN1454597A Oral slow-release and controlled-release preparation for curing depression |
| 11/12/2003 | CN1454594A Nicardipine hydrochloride controlled-release preparation |
| 11/12/2003 | CN1454590A Ethylenediamine diaceturate lyophilized powder injection and preparing method thereof |
| 11/12/2003 | CN1454589A Coenzyme Q10 aseptic freee-drying preparation for injection and its preparing method |
| 11/12/2003 | CN1454588A Polypeptide protein oral nano particle preparation |
| 11/12/2003 | CN1127535C Method for controlling drug permeation |
| 11/12/2003 | CN1127502C Salts of paroxetine |
| 11/12/2003 | CN1127477C Methods and compositions for lipidization of hydrophilic molecules |
| 11/12/2003 | CN1127350C Cyclosorin-containing soft capsule preparations |
| 11/12/2003 | CN1127345C Process for preparing liquid medicine to care verrucosis and gonorrhea |
| 11/12/2003 | CN1127344C Oral pill for treating diabetes and its complication |
| 11/12/2003 | CN1127340C Composition containing nicotine compound, use thereof and its formation method |
| 11/12/2003 | CN1127338C Anti-vaginitis composition for topiical use comprising one or move anti-vaginitis medicaments and one or more local anaesthetics |
| 11/12/2003 | CN1127334C Water-soluble or water-dispersible polyurethanes coatings or binders for medicine coating |
| 11/12/2003 | CN1127333C Local pharmaceutical composition comprising cholinergic agent or calcium channel blocker |
| 11/11/2003 | US6646162 Compounds and compositions for delivering active agents |
| 11/11/2003 | US6646007 Process for preparing a pharmaceutical formulation containing levothyroxine sodium |
| 11/11/2003 | US6645988 Pharmaceutical preparations comprising substituted benzimidazole proton pump inhibitors with fast acting buffer; gastric acid stability for enteral administration |
| 11/11/2003 | US6645978 Topical mixtures comprising mucin stimulants and carriers, for prophylaxis trauma from surgery or contact lenses |
| 11/11/2003 | US6645963 Prolonged-action eye drop |
| 11/11/2003 | US6645961 Dry granulation formulation for an HIV protease inhibitor |
| 11/11/2003 | US6645946 Delivery of a therapeutic agent in a formulation for reduced toxicity |
| 11/11/2003 | US6645936 Administering ophthalmic lactoferrin solution to eyes of patient after sclerocorneal incision as wound healing agent |
| 11/11/2003 | US6645535 Method of making coated chewing gum products containing various antacids |
| 11/11/2003 | US6645532 Compositions and method for relieving discomfort in the ears |
| 11/11/2003 | US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound |
| 11/11/2003 | US6645529 Soluble coatings; variations in bulk density |
| 11/11/2003 | US6645528 Rate of dissolution of drugs can be enhanced by making the drug into a porous matrix form |
| 11/11/2003 | US6645527 Stabilized sustained release tramadol formulations |
| 11/11/2003 | US6645526 Storage-stable dosage form of a thyroxine active drug formulation for the treatment of thyroid, containing levothyroxine sodium as active drug substance, an alditol and a sacchride; increased shelf-life |
| 11/11/2003 | US6645525 Complex comprising a cationic polymer ionically complexed with an anionic polymer, polyethyleneimine and dextran sulfate, repectively; biomolecule is ionically complexed with the cationic or anionic polymer |
| 11/11/2003 | US6645524 Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
| 11/11/2003 | US6645523 Paroxetine compositions and processes for making the same |
| 11/11/2003 | US6645522 Erythropoietin or derivatives that cause bone marrow cells to increase production of reticulocytes and erythrocytes; hydrogenated lecithin that may be hydrogenated; cholesterol or a derivative; phosphate buffer |
| 11/11/2003 | US6645521 Local prevention or amelioration of pain from surgically closed wounds |
| 11/11/2003 | US6645520 Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers |
| 11/11/2003 | US6645516 Hydrosoluble composition comprising lipophilic vegetable material and at least two ecologically optimized surfactants |
| 11/11/2003 | US6645510 Method of treating topical ailments |
| 11/11/2003 | US6645507 Skin product having continuing antimicrobial, antiviral, antiseptic, and healing properties |
| 11/11/2003 | US6645506 Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil |
| 11/11/2003 | US6645504 Certain antigens (called "bystander antigens" and defined below) causes T-cells to be elicited that in turn suppress cells that contribute to immune attack of the organ or tissue involved in an autoimmune disease |
| 11/11/2003 | US6645495 Compositions of saponin adjuvants and excipients |
| 11/11/2003 | US6645488 Microencapsulated pheochromocyte of ox adrenal medulla as medicine for curing pain |
| 11/11/2003 | US6645476 Preparable by free-radical copolymerization of macromonomers containing an end-group capable of polymerization, a hydrophilic moiety based on polyalkylene oxides, and a hydrophobic moiety with olefincally unsaturated comonomers |
| 11/11/2003 | US6645469 Method for dispensing S-adenosyl-methionine in a micro fine powdered form by inhalation |
| 11/11/2003 | US6645468 Medicinal aerosol formulation |
| 11/11/2003 | US6645467 Administering a dose of a mixture of lipid crystals, as an aerosol; propellants are evaporated as aerosolized mixture of lipid crystals come into contact with, and deposits upon the epithelial lining of the upper respiratory system |
| 11/11/2003 | US6645466 Dry powder for inhalation |
| 11/11/2003 | US6645463 Blood-pool selective carrier for lipophilic imaging agents |
| 11/11/2003 | US6645192 Pellet implant system for immediate and delayed release of antiparasitic drug |
| 11/11/2003 | US6645167 Methods for embolizing vascular sites with an embolizing composition |
| 11/11/2003 | CA2377118C Antipsoriatic compositions, method of making, and method of using |
| 11/11/2003 | CA2265906C System for delivery of drugs by transport |
| 11/11/2003 | CA2168246C Preparations of crataegus species, pharmaceutical compositions and their use for preventing sudden death due to cardiac arrest and reperfusion-caused cardiovascular lesions |
| 11/11/2003 | CA2124568C Method for producing microgranulated particle |
| 11/11/2003 | CA2039456C Osmotic dosage system for liquid drug delivery |
| 11/08/2003 | CA2427778A1 Capsules printed with sepia colored containing inks |
| 11/06/2003 | WO2003091432A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription |
| 11/06/2003 | WO2003091387A2 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 11/06/2003 | WO2003091337A1 New polyarylates for drug delivery and tissue engineering |
| 11/06/2003 | WO2003091299A1 Hydrophilic polymers and methods of preparation |
| 11/06/2003 | WO2003091290A1 Method for reduction of residual organic solvent in carbomer |
| 11/06/2003 | WO2003091283A1 Gelatin derivatives and high-molecular micelles comprising the same |
| 11/06/2003 | WO2003091276A2 Compositions and methods of use of peptides in combination with biocides and/or germicides |
| 11/06/2003 | WO2003090818A2 Drug-delivery endovascular stent and method for treating restenosis |
| 11/06/2003 | WO2003090806A1 Modulation of therapeutic agent release from a polymeric carrier using solvent-based techniques |
| 11/06/2003 | WO2003090805A1 Process for production of hydrogel material enhanced in the intake of drugs and permitting sustained release of drugs |
| 11/06/2003 | WO2003090800A1 Wound dressings comprising hydrated hydrogels and enzymes |
| 11/06/2003 | WO2003090798A1 Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine |
| 11/06/2003 | WO2003090767A1 An injection made from ixeris sonchifolia for treatment of cardio-cerebral vascular disease and fundus diseases and method of producing thereof |
| 11/06/2003 | WO2003090763A1 Composition and kit for the treatment of inflammatory bowel diseases |
| 11/06/2003 | WO2003090762A1 Long acting compositions comprising zidovudine and lamivudine |
| 11/06/2003 | WO2003090757A1 Pharmaceutical compositions of phospholipid derivatives |
| 11/06/2003 | WO2003090742A1 Pharmaceutical composition comprising a lipase inhibitor and glucomannan |
| 11/06/2003 | WO2003090739A1 Use of conjugated linoleic acid derivatives |
| 11/06/2003 | WO2003090738A1 Stress inhibition composition, theanine-containing granule and process for producing the same |
| 11/06/2003 | WO2003090734A1 Tolterodine salts |
| 11/06/2003 | WO2003090729A1 Transdermal analgesic systems with reduced abuse potential |
| 11/06/2003 | WO2003090728A1 Use of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix |
| 11/06/2003 | WO2003090727A1 Colloidal suspension of submicronic particles for delivering active principles and method for preparing same |
| 11/06/2003 | WO2003090726A2 Chewable soft capsule |
| 11/06/2003 | WO2003090725A1 Capsule preparation |
| 11/06/2003 | WO2003090724A1 Coated particles with prolonged release and tablets containing same |
| 11/06/2003 | WO2003090723A1 Modified-release vasopeptidase inhibitor formulation, combinations and method |
| 11/06/2003 | WO2003090722A2 Microparticle pharmaceutical compositions for intratumoral delivery |
| 11/06/2003 | WO2003090721A2 Method for producing crystals from active ingredients in medicaments, and the use thereof in pharmaceutical formulations |
| 11/06/2003 | WO2003090720A1 High drug load tablet |
| 11/06/2003 | WO2003090719A1 Histidine copolymer and methods for using same |
| 11/06/2003 | WO2003090718A1 Air treatment gel and method for its preparation |